NEWPORT NEWS, Va., Nov. 24, 2015 /PRNewswire/ -- DILON Diagnostics and GE Healthcare are pleased to announce that they have signed an agreement for DILON to distribute GE's Discovery NM750b Molecular Breast Imaging system in select geographies across the globe. The signing of this distribution agreement will provide Dilon's experienced distribution network access to GE's Discovery NM750b Molecular Breast Imaging system and is considered an initial step in an ongoing exploration of ways to provide better healthcare solutions for clinicians and their patients.
The Discovery NM750b breast imaging system, designed to provide significant enhancement in lesion detectability, offers clinicians an important tool for imaging of a broad range of patients, including those with dense breast who may be at higher risk for breast cancer. The power of functional imaging to see early changes is a key factor in early detection in breast cancer.
"We are very pleased to associate with GE Healthcare, a world leader in innovation, in the fight against breast cancer," says Robert G. Moussa, DILON Diagnostics Chairman and CEO. "This relationship will enable us to expand our product portfolio and offer a complete spectrum of BSGI/MBI solutions to better meet the needs of our customers."
"We are excited to make the Discovery NM750b breast imaging system further available and to benefit from DILON's global and solid network of sales representatives," says Nathan Hermony, Nuclear Imaging global business manager for GE Healthcare. "GE believes strongly in this advanced technology and the potential for this type of imaging to improve breast cancer diagnosis. DILON Diagnostics resources will bring further the education and acceptance of Molecular Breast Imaging," he adds.
About DILON Diagnostics
DILON Diagnostics, a brand of DILON Technologies, Inc., located in Newport News, Virginia, designs, manufactures and commercializes innovative medical imaging solutions worldwide. DILON's cornerstone product, the DILON Molecular Imaging System, is a high-resolution, compact camera for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The DILON Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. For more information on DILON Diagnostics please visit www.dilon.com
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information visit our website www.gehealthcare.com
Media contact: Pjerin Luli
Logo - http://photos.prnewswire.com/prnh/20140106/PH40697LOGO
Logo - http://photos.prnewswire.com/prnh/20151124/290662LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dilon-diagnostics-and-ge-healthcare-announce-a-global-distribution-agreement-for-the-discovery-nm750b-molecular-breast-imaging-system-300184022.html
SOURCE Dilon Technologies, Inc.